{
    "name": "inclisiran",
    "comment": "Rx",
    "other_names": [
        "Leqvio"
    ],
    "classes": [
        "Lipid-Lowering Agents",
        "PCSK9 Inhibitors",
        "Lipid-Lowering Agents",
        "siRNA"
    ],
    "source": "https://reference.medscape.com/drug/leqvio-inclisiran-4000063",
    "pregnancy": {
        "common": [
            "No data are available on use in pregnant females for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Discontinue therapy when pregnancy is recognized",
            "Based on mechanism of action, therapy may cause fetal harm when administered to pregnant females"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "No evidence of embryo-fetal toxicity or teratogenicity was observed in rats with SC administration during organogenesis at doses up to 5-10x the maximum recommended human dose (MRHD)",
                    "No effects on the development of the F1 generation (eg, survival, growth, physical and reflexological development, behavior, and reproductive performance) were observed at doses up to 5x the MRHD, based on body surface area comparison/dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There is no information on drug presence in human milk, effects on breastfed infants, or effects on milk production",
            "Inclisiran was present in the milk of lactating rats in all dosing groups",
            "When a drug is present in animal milk, it is likely that the drug will be present in human milk",
            "Oligonucleotide-based products usually have poor bioavailability; consider it unlikely that low levels of inclisiran present in milk will adversely impact an infantâ€™s development during lactation"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site reaction",
            "percent": "8.2"
        },
        {
            "name": "Arthralgia",
            "percent": "5"
        },
        {
            "name": "Urinary tract infection",
            "percent": "4.4"
        },
        {
            "name": "Bronchitis",
            "percent": "4.3"
        },
        {
            "name": "Diarrhea",
            "percent": "3.9"
        },
        {
            "name": "Pain in extremity",
            "percent": "3.3"
        },
        {
            "name": "Dyspnea",
            "percent": "3.2"
        }
    ]
}